Kidney drug under the microscope: how safe is finerenone in daily use?
NCT ID NCT06608212
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 33 times
Summary
This study looks at health records from 150,000 people with chronic kidney disease and type 2 diabetes to see how safe and effective the drug finerenone is in everyday medical care. Researchers will compare those who take finerenone with those who do not, focusing on heart attacks and hospitalizations for heart failure. No extra visits or tests are needed—only existing data from routine care is used.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Bayer
Whippany, New Jersey, 07981, United States
Conditions
Explore the condition pages connected to this study.